Status:
COMPLETED
Development of Early Detection Signs for Gastrointestinal Cancer
Lead Sponsor:
University of Pittsburgh
Conditions:
GI Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Therapies involving the immune system have already shown great promise in early clinical trials for the treatment of renal cell carcinoma and melanoma. One of the great challenges now facing this fiel...
Detailed Description
The first goal of this proposal is to collect cells from the peripheral blood, tumor draining lymph nodes and tumor infiltrating lymphocytes in patients with early or late stage gastrointestinal cance...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- histologically confirmed GI malignancy
- suspected GI malignancy
- high risk individual as assessed by their physician
Exclusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 17 2016
Estimated Enrollment :
2499 Patients enrolled
Trial Details
Trial ID
NCT00633334
Start Date
September 1 2003
End Date
February 17 2016
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States, 15232